Residency: Oct. 3-7, 2016
"Biomedical Research: Lessons from Global Health"
Oct. 5, 2016
Sir Tadataka Yamada, the former director of the Bill & Melinda Gates Foundation Global Health Program, discussed key global health issues and current trends of biomedical research and its impact.
Sir Tadataka Yamada guides and advises portfolio management and company creation in the life sciences at Frazier. Before his current role, Sir Yamada was the chairman of research and development at GlaxoSmithKline, the director of Global Health at the Bill & Melinda Gates Foundation, as well as chief scientific officer at Takeda Pharmaceuticals in Tokyo.
Sir Yamada has emphasized the power of partnerships in health care between large pharmaceutical companies and philanthropic foundations. While at the Gates Foundation, he oversaw massive development in infectious disease immunization as well as in maternal-child healthcare.
Prior to his work in entrepreneurship and medical development, Sir Yamada developed a rich background in medicine. He currently serves as a fellow or board member of a variety of major national medical institutions, as well as on the Clinton Health Access Initiative Board of Directors. He has received awards for his contribution to medical science from the U.S., United Kingdom and Mexico among others. Sir Yamada received his M.D. from New York University School of Medicine.
During his residency, he explored diverse health care topics including global health policy.